c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation

c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation

Parkinson’s disease (PD) stands as the second most prevalent neurodegenerative disorder, impacting a global population estimated between 6 to 10 million individuals. The condition primarily arises from a dopamine deficiency and the presence of α-synuclein, forming Lewy bodies in the substantia nigra...

Full description

Saved in:
Bibliographic Details
Main Authors: Jyutia Nargish, Hirok Jyoti Baishya, Piyong Sola
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2025-04-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
parkinson’s disease
neurodegeneration
c-abl
α-synuclein
phosphorylation
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-15-7.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items